ALT-100mAb

ALT-100 monoclonal antibody · Aqualung Therapeutics Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALT-100mAb, covering 2025-10-23 to 2025-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS [Phase 2]